Search Results - "Krakamp, B"

Refine Results
  1. 1
  2. 2
  3. 3

    Is the transnasal access for esophagogastroduodenoscopy in routine use equal to the transoral route? A prospective, randomized trial by Knuth, J, Kunze, D E, Benz, C, Bulian, D R, Heiss, M M, Lefering, R, Saad, S, Saers, T, Krakamp, B

    Published in Zeitschrift fur Gastroenterologie (01-12-2013)
    “…Routine esophagogastroduodenoscopy (EGD) is increasingly performed without sedation. Transoral (TO) and transnasal (TN) EGD offer different patient comfort and…”
    Get more information
    Journal Article
  4. 4

    Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses by Kruis, W, Schreiber, S, Theuer, D, Brandes, J-W, Schütz, E, Howaldt, S, Krakamp, B, Hämling, J, Mönnikes, H, Koop, I, Stolte, M, Pallant, D, Ewald, U

    Published in Gut (01-12-2001)
    “…BACKGROUND Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug. Its efficacy in comparison with standard mesalazine therapy and the optimum…”
    Get full text
    Journal Article
  5. 5

    Uncommon condition of the upper gastrointestinal tract: double pylorus by Wurm, G, Saers, T, Weber, M, Krakamp, B

    Published in Zeitschrift für Gastroenterologie (01-02-2009)
    “…Double pylorus and gastroduodenal fistula are uncommon conditions that are either congenital or acquired. Acquired double pylorus in most cases resulted from a…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis by KRUIS, W, BRANDES, J.-W, SCHREIBER, S, THEUER, D, KRAKAMP, B, SCHÜTZ, E, OTTO, P, LORENZ-MAYER, H, EWE, K, JUDMAIER, G

    Published in Alimentary pharmacology & therapeutics (01-08-1998)
    “…Aim: To compare the efficacy and tolerability of olsalazine sodium with enteric‐coated mesalazine in inducing endoscopic remission in patients with mild to…”
    Get full text
    Journal Article
  9. 9

    Positron emission tomography reveals a leiomyosarcoma causing proteinuria by Hegner, B, Krakamp, B, Hedde, J P, Brockmann, M, Weber, M, Schulze-Lohoff, E

    Published in Clinical nephrology (01-08-2003)
    “…Obstruction of the renal veins may result in proteinuria and is frequently caused by thrombosis or tumorous processes. Since thrombosis and malignancy may…”
    Get more information
    Journal Article
  10. 10

    Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction by KRAKAMP, B, TANSWELL, P, VOGEL, H, BOZLER, G

    “…The steady-state intravenous pharmacokinetics of pirenzepine has been investigated in 57 subjects whose renal function ranged from normal to chronic failure…”
    Get full text
    Journal Article
  11. 11

    Diamine oxidase activities in the large bowel mucosa of ulcerative colitis patients by Mennigen, R, Kusche, J, Streffer, C, Krakamp, B

    Published in Agents and Actions (01-04-1990)
    “…The term colitis suggests mucosal inflammation as the key event. However, it may be that the disease starts with mucosal hyperproliferation, and inflammation…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Large bowel tumor promotion by diamine oxidase inhibition: animal model and clinical aspects by Kusche, J, Menningen, R, Leisten, L, Krakamp, B

    “…In the intestinal mucosa, diamine oxidase probably is involved in a feedback regulation mechanism for the termination of proliferation. This was proven by a…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Large bowel tumors and diamine oxidase (DAO) activity in patients: a new approach for risk group identification by Mennigen, R, Kusche, J, Krakamp, B, Elbers, A, Amoei, B, Kessebohm, M, Sommer, H

    Published in Agents and Actions (01-04-1988)
    “…In the intestinal mucosa, diamine oxidase (DAO) seems to be involved in a feed-back regulation mechanism for the termination of proliferation. Therefore, we…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Pharmacokinetics of isosorbide-5-nitrate in renal failure by EVERS, J, KRAKAMP, B, KLIMKAIT, W, DICKMANS, H. A, MADDOCK, J, LUCKOW, V, CAWELLO, W, WEISS, M

    Published in European journal of clinical pharmacology (01-01-1986)
    “…The pharmacokinetics of the antianginal drug isosorbide-5-nitrate (IS-5-N) was studied in 20 patients with varying degrees of chronic renal failure after…”
    Get full text
    Journal Article
  20. 20

    Prospective study comparing conventional and transnasal esophagogastroduodenoscopy for routine diagnosis by Krakamp, B, Parusel, M, Saers, T

    Published in Deutsche medizinische Wochenschrift (16-01-2004)
    “…Transnasal gastroscopy (TNG) is the result of ongoing improvements in endoscopic device development. These ultrathin endoscopes are planned to improve patient…”
    Get more information
    Journal Article